New Zealand Healthcare Services Stock News

Recent projections for strong growth in China’s baby food market, driven by higher disposable incomes, urbanization, and a rising focus on infant nutrition, put a2 Milk (NZSE:ATM) firmly in the spotlight as one of the sector’s key players. See our latest analysis for a2 Milk. a2 Milk’s share price has recently been under pressure, with a 30 day share price return of 20.18% decline and a year to date share price return of 17.13% decline, even as the 3 year total shareholder return sits at...

Fisher & Paykel Healthcare (NZSE:FPH) is back in focus after recent share price moves, with the stock showing a 0.7% decline over the past day and softer returns over the past month. See our latest analysis for Fisher & Paykel Healthcare. While the 1-day share price return of 0.72% and 7-day share price return of 5.80% point to softer short term momentum, the 1-year total shareholder return of 5.57% and 3-year total shareholder return of 34.95% indicate that longer term holders have still...

Genesis Energy has confirmed it reached a Final Investment Decision on 17 April 2026 for Stage 2 of its Battery Energy Storage System at Huntly Power Station, committing roughly NZ$106 million to add 100MW / 200MWh of consented, grid-connected capacity by the third quarter of fiscal 2028. This expansion, funded on balance sheet after a recent NZ$400 million equity raise, is positioned as New Zealand’s lowest-cost committed grid-scale BESS to date and a key milestone in Genesis’ Gen35 growth...

Genesis Energy (NZSE:GNE) has committed to a second stage of battery storage at Huntly Power Station, approving a 100MW / 200MWh expansion that supports its Gen35 plan and shift away from baseload gas. See our latest analysis for Genesis Energy. The Huntly BESS expansion comes as Genesis Energy’s 1 month share price return of 8.8% and 7 day return of 4.4% contrast with a year to date share price decline of 2.1%. At the same time, the 1 year total shareholder return of 17.1% and positive 3...

Readers hoping to buy Scott Technology Limited ( NZSE:SCT ) for its dividend will need to make their move shortly, as...

As Asian markets navigate a landscape marked by geopolitical developments and economic data releases, small-cap stocks are capturing attention with their potential for growth amid broader market movements. In this context, insider buying can serve as a valuable indicator of confidence in these companies' prospects, offering insights into which stocks might be positioned to capitalize on current conditions.

Ryman Healthcare Limited reported that total sales of occupation right agreements for retirement village units rose to 331 in the fourth quarter ended 31 March 2026, up from 302 a year earlier. This lift in quarterly unit sales points to firmer demand for Ryman’s retirement village offering, an important indicator for ongoing village occupancy and cash generation. We’ll now examine how this stronger fourth-quarter unit sales performance shapes Ryman Healthcare’s investment narrative and...

Ryman Healthcare (NZSE:RYM) has drawn investor attention after reporting fourth quarter sales of 331 occupation right agreements for retirement village units, compared with 302 a year earlier, in its latest trading statement. See our latest analysis for Ryman Healthcare. The trading update comes after a mixed run in the share price, with a 3.98% 1 day share price return and a 0.97% 7 day share price return, set against a 27.93% 90 day share price decline and a 57.76% 3 year total shareholder...

Why Fonterra’s CEO Change Matters For Shareholders Fonterra Co-operative Group (NZSE:FCG) has announced that long-time executive Richard Allen will become CEO on May 1, 2026, with outgoing chief Miles Hurrell staying on as an adviser until September. This internal appointment, following Allen’s senior roles across ingredients, foodservice, Farm Source and international operations, keeps attention on how leadership continuity might influence Fonterra’s scale, capital allocation and dividend...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Scott Technology (NZSE:SCT) H1 2026 earnings snapshot Scott Technology (NZSE:SCT) has reported fresh numbers for H1 2026, with revenue of NZ$153.5 million and basic EPS of NZ$0.119, alongside net income of NZ$10.0 million. Over recent halves the company recorded revenue of NZ$135.3 million in H2 2024, NZ$121.7 million in H1 2025 and NZ$153.5 million in H2 2025. Over the same periods, basic EPS moved from NZ$0.0418 to NZ$0.054 and then to NZ$0.119, making this release a useful check on how...

We feel now is a pretty good time to analyse Serko Limited's ( NZSE:SKO ) business as it appears the company may be on...

Warehouse Group (NZSE:WHS) has just posted its H1 2026 scorecard, with trailing twelve month revenue of NZ$3.1b and basic EPS of NZ$0.003, while the latest reported half year, H2 2025, showed revenue of NZ$1,479.5 million and a net income loss of NZ$14.6 million. Over recent halves, revenue has moved from NZ$1,404.9 million in H2 2024 to NZ$1,607.2 million in H1 2025 and then to NZ$1,479.5 million in H2 2025, with EPS swinging between a loss of NZ$0.074, a profit of NZ$0.034, and a loss of...

Hallenstein Glasson Holdings (NZSE:HLG) has kicked off H1 2026 reporting with trailing 12 month revenue of NZ$505.9 million and basic EPS of NZ$0.78, set against a year where earnings grew 33.9% and the net margin was 9.1%. The company has seen revenue move from NZ$452.7 million to NZ$505.9 million over the last three trailing periods, while basic EPS stepped from NZ$0.58 to NZ$0.78. This gives a clear view of how sales and profits are tracking into the latest half. With that backdrop of...

Q2 2026 earnings snapshot Fonterra Co-operative Group (NZSE:FCG) has just put fresh numbers on the table, with the latest reported quarter showing revenue of NZ$4.4 billion and a basic EPS loss of NZ$0.10, set against a trailing twelve month EPS of NZ$0.62 and revenue of NZ$24.1 billion. Over recent periods the co operative has seen quarterly revenue range from NZ$3.4 billion to NZ$7.1 billion, while basic EPS has swung between a loss of NZ$0.10 and a profit of NZ$0.25, giving investors a...

Synlait Milk (NZSE:SML) has put fresh numbers on the table for H1 2026, with revenue of about NZ$910.6 million and basic EPS of a loss of NZ$0.07, alongside net income of a loss of NZ$44.6 million. The company has seen revenue move from NZ$843.3 million in H2 2024 to NZ$916.8 million in H1 2025 and NZ$910.6 million in H2 2025. EPS has shifted from a loss of NZ$0.39 in H2 2024 to EPS of NZ$0.01 in H1 2025 and back to a loss of NZ$0.07 in H2 2025, presenting a picture where top line scale is...

Contact Energy (NZSE:CEN) has raised NZ$125 million through a follow on equity offering of 14,285,714 new ordinary shares at NZ$8.75. This move directly affects existing shareholders. See our latest analysis for Contact Energy. The follow on offer comes at a time when momentum has cooled slightly. The latest share price is NZ$9.24, with a modest 1 year total shareholder return of 13.98% and a stronger 5 year total shareholder return of 73.79%, which points to longer term resilience. If this...

Chorus recently launched its ‘Equity Fibre 100’ wholesale product in New Zealand, offering 100/20 Mbps fibre broadband with a retail price cap of NZ$30 per month for eligible low-income households as part of a digital inclusion initiative. This move highlights Chorus’s effort to improve broadband access for eligible households facing financial hardship...

Spark New Zealand (NZSE:SPK) has put investors on alert after reporting a 15.5% year-over-year drop in adjusted EBITDA for the first half of FY2025 and cutting full year EBITDA guidance. See our latest analysis for Spark New Zealand. The latest results have come after a mixed share price run, with Spark New Zealand’s recent 1 month share price return of 3.2% contrasting with a 1 year total shareholder return of 14.5% and weaker 3 and 5 year total shareholder returns. This suggests momentum...

Briscoe Group (NZSE:BGP) has opened FY 2026 with first half revenue of NZ$371.3 million, basic EPS of NZ$0.1315 and net income of NZ$29.3 million, setting the tone for how the rest of the year might shape up. Over the last few halves, the company has seen revenue move from NZ$372.1 million in FY 2025 H1 to NZ$419.4 million in FY 2025 H2 and EPS shift from NZ$0.1491 to NZ$0.1231. The latest trailing twelve month EPS is NZ$0.266 on revenue of NZ$798.8 million. With net profit margin now at...

Air New Zealand (NZSE:AIR) is back in focus after reporting a net loss of NZ$40 million for the half year to December 31, 2025, and announcing no interim dividend for the period. See our latest analysis for Air New Zealand. The weak half-year result and the decision to skip an interim dividend sit alongside a 1 day share price return of 1.08% decline and a 1 year total shareholder return of 25.44% decline, pointing to fading momentum rather than a short-term wobble. If this kind of setback...

Spark New Zealand reported in early 2026 that its adjusted EBITDA for the first half of FY2025 fell 15.5% year over year, prompting a reduction in full-year EBITDA guidance amid tougher economic conditions and a weaker enterprise mobile business. In response, Spark is launching a cost-cutting program targeting NZ$110–140 million in savings and pursuing long-term data center co-investments, while also working with other New Zealand telecom operators on shared fraud-prevention APIs to bolster...

Event backdrop and why Fletcher Building is on the radar Fletcher Building (NZSE:FBU) is back in focus after subsidiary Higgins Contractors signed 10 year integrated delivery contracts with the New Zealand Transport Agency, while New Zealand shares have been soft amid rising Middle East related geopolitical risks. See our latest analysis for Fletcher Building. At a share price of NZ$3.45, Fletcher Building has had a 30 day share price return of 8.49% and a year to date share price return of...

Why EBOS Group’s latest half year result is getting attention EBOS Group (NZSE:EBO) has landed on investor watchlists after its half year 2025 earnings update, with higher sales, higher net income and reaffirmed EBITDA guidance all arriving alongside a steady interim dividend. See our latest analysis for EBOS Group. Despite the solid half year update and the interim dividend of NZ$0.57 per share, EBOS Group’s share price has slipped to NZ$23.96, with a 30 day share price return of 6.81% and a...